Deva Holding A.S.
Deva Holding, established in 1958, is one of Turkey’s longest-established pharmaceutical manufacturers. It operates in the production and marketing of pharmaceuticals and pharmaceutical raw materials, with a focus on innovation, quality, and sustainability. The company has a broad product portfolio spanning multiple therapeutic areas and is committed to leading in the development of equivalent drugs. Deva Holding has manufacturing facilities in Kartepe, Çerkezköy, and a logistics center, with a strong emphasis on research and development, quality policies, and international market expansion.
Industries
Nr. of Employees
Very Large (1000+)
Deva Holding A.S.
Products
Broad finished pharmaceutical product portfolio
Extensive catalog of finished pharmaceuticals across multiple therapeutic areas offered in a variety of dosage forms including film-coated tablets, modified/extended-release tablets, capsules, soft-gels, sterile injectables, lyophilized powders and nebulization solutions; portfolio supports domestic and international supply including oncology and animal health products.
Broad finished pharmaceutical product portfolio
Extensive catalog of finished pharmaceuticals across multiple therapeutic areas offered in a variety of dosage forms including film-coated tablets, modified/extended-release tablets, capsules, soft-gels, sterile injectables, lyophilized powders and nebulization solutions; portfolio supports domestic and international supply including oncology and animal health products.
Services
On-site manufacture of solid, liquid, semi-solid, sterile injectable, lyophilized and inhalation dosage forms at commercial scale, including dedicated oncology and API manufacturing units.
On-site and collaborative R&D services including formulation development, API synthesis and scale-up, biotechnology research and development of generics and novel formulations.
Advisory services for regulatory submissions, product registration and market access across multiple international jurisdictions.
On-site logistics operations for temperature-controlled storage, handling and distribution of finished pharmaceutical and consumer health products.
On-site manufacture of solid, liquid, semi-solid, sterile injectable, lyophilized and inhalation dosage forms at commercial scale, including dedicated oncology and API manufacturing units.
On-site and collaborative R&D services including formulation development, API synthesis and scale-up, biotechnology research and development of generics and novel formulations.
Advisory services for regulatory submissions, product registration and market access across multiple international jurisdictions.
On-site logistics operations for temperature-controlled storage, handling and distribution of finished pharmaceutical and consumer health products.
Expertise Areas
- Commercial pharmaceutical manufacturing (sterile and non-sterile)
- Oncology product manufacturing (solid and sterile)
- Formulation development and process scale-up (including modified-release)
- Active pharmaceutical ingredient (API) synthesis and on-site API manufacturing
Key Technologies
- Solid oral dosage formulation and tablet/capsule production
- Liquid formulation and sterile injectable manufacturing
- Lyophilization (freeze-drying)
- Aseptic filling and sterile processing